Molecular Mechanisms Mediating Relapse Following Ivosidenib Monotherapy in Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia

被引：2
|
作者：
Choe, Sung [1 ]
Wang, Hongfang [1 ]
DiNardo, Courtney D. [2 ]
Stein, Eytan M. [3 ]
De Botton, Stephane [4 ]
Fathi, Amir T. [5 ]
Tallman, Martin S. [3 ]
Kantarjian, Hagop M. [2 ]
Stone, Richard M. [6 ]
Quek, Lynn [7 ]
Konteatis, Zenon [1 ]
Dang, Lenny [1 ]
Zhang, Vickie [1 ]
Liu, Hua [1 ]
Attar, Eyal C. [1 ]
Wu, Bin [1 ]
机构：
[1] Agios Pharmaceut Inc, Cambridge, MA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Inst Gustave Roussy, Villejuif, France
[5] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Univ Oxford, Oxford, England
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122671
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
545
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
    Choe, Sung
    Wang, Hongfang
    DiNardo, Courtney D.
    Stein, Eytan M.
    de Botton, Stephane
    Roboz, Gail J.
    Altman, Jessica K.
    Mims, Alice S.
    Watts, Justin M.
    Pollyea, Daniel A.
    Fathi, Amir T.
    Tallman, Martin S.
    Kantarjian, Hagop M.
    Stone, Richard M.
    Quek, Lynn
    Konteatis, Zenon
    Dang, Lenny
    Nicolay, Brandon
    Nejad, Parham
    Liu, Guowen
    Zhang, Vickie
    Liu, Hua
    Goldwasser, Meredith
    Liu, Wei
    Marks, Kevin
    Bowden, Chris
    Biller, Scott A.
    Attar, Eyal C.
    Wu, Bin
    BLOOD ADVANCES, 2020, 4 (09) : 1894 - 1905
  • [2] EXPOSURE-RESPONSE ANALYSIS OF IVOSIDENIB IN PATIENTS WITH IDH1-MUTANT RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA.
    Le, K.
    Kleijn, H. J.
    Dai, D.
    Fan, B.
    Liu, H.
    Attar, E. C.
    Hickman, D.
    Agresta, S. V.
    Yang, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S85 - S85
  • [3] Complex Polyclonal Resistance Mechanisms to Ivosidenib Monotherapy in IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia Revealed By Single Cell Sequencing Analyses
    Wang, Hongfang
    Choe, Sung
    DiNardo, Courtney D.
    Stein, Eytan M.
    de Botton, Stephane
    Fathi, Amir T.
    Tallman, Martin S.
    Kantarjian, Hagop M.
    Stone, Richard M.
    Quek, Lynn
    Zhang, Vickie
    Liu, Hua
    Attar, Eyal C.
    Wu, Bin
    BLOOD, 2019, 134
  • [4] Ivosidenib (IVO) prior to hematopoietic cell transplant for patients with IDH1-mutant relapsed or refractory acute myeloid leukemia (R/R AML).
    Dinardo, Courtney Denton
    Stein, Eytan
    Pigneux, Arnaud
    Altman, Jessica K.
    Collins, Robert
    Erba, Harry Paul
    Watts, Justin M.
    Uy, Geoffrey L.
    Kapsalis, Stephanie M.
    Liu, Hua
    Winkler, Thomas
    Roboz, Gail J.
    de Botton, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Molecular Characterization of Clinical Response and Relapse in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib and Azacitidine
    Daigle, Scott R.
    Choe, Sung
    DiNardo, Courtney D.
    Stein, Anthony S.
    Stein, Eytan M.
    Fathi, Amir T.
    Frankfurt, Olga
    Schuh, Andre C.
    Dohner, Hartmut
    Martinelli, Giovanni
    Patel, Prapti A.
    Raffoux, Emmanuel
    Tan, Peter
    Zeidan, Amer M.
    De Botton, Stephane
    Stone, Richard M.
    Frattini, Mark
    Franovic, Aleksandra
    Xu, Emily
    Winkler, Thomas
    Wu, Bin
    Vyas, Paresh
    BLOOD, 2020, 136
  • [6] Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant
    DiNardo, Courtney D.
    Stein, Eytan M.
    Pigneux, Arnaud
    Altman, Jessica K.
    Collins, Robert
    Erba, Harry P.
    Watts, Justin M.
    Uy, Geoffrey L.
    Winkler, Thomas
    Wang, Hongfang
    Choe, Sung
    Liu, Hua
    Wu, Bin
    Kapsalis, Stephanie M.
    Roboz, Gail J.
    de Botton, Stephane
    LEUKEMIA, 2021, 35 (11) : 3278 - 3281
  • [7] Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant
    Courtney D. DiNardo
    Eytan M. Stein
    Arnaud Pigneux
    Jessica K. Altman
    Robert Collins
    Harry P. Erba
    Justin M. Watts
    Geoffrey L. Uy
    Thomas Winkler
    Hongfang Wang
    Sung Choe
    Hua Liu
    Bin Wu
    Stephanie M. Kapsalis
    Gail J. Roboz
    Stéphane de Botton
    Leukemia, 2021, 35 : 3278 - 3281
  • [8] Longitudinal Molecular Profiling in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib
    Choe, Sung
    Wang, Hongfang
    Roboz, Gail J.
    DiNardo, Courtney D.
    Stein, Eytan M.
    Mims, Alice S.
    Prince, Gabrielle T.
    Watts, Justin M.
    Fan, Bin
    Nejad, Parham
    Zhang, Vickie
    Liu, Hua
    Attar, Eyal C.
    Wu, Bin
    Stone, Richard M.
    BLOOD, 2020, 136
  • [9] Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
    Roboz, Gail J.
    DiNardo, Courtney D.
    Stein, Eytan M.
    de Botton, Stephane
    Mims, Alice S.
    Prince, Gabrielle T.
    Altman, Jessica K.
    Arellano, Martha L.
    Donnellan, Will
    Erba, Harry P.
    Mannis, Gabriel N.
    Pollyea, Daniel A.
    Stein, Anthony S.
    Uy, Geoffrey L.
    Watts, Justin M.
    Fathi, Amir T.
    Kantarjian, Hagop M.
    Tallman, Martin S.
    Choe, Sung
    Dai, David
    Fan, Bin
    Wang, Hongfang
    Zhang, Vickie
    Yen, Katharine E.
    Kapsalis, Stephanie M.
    Hickman, Denice
    Liu, Hua
    Agresta, Samuel, V
    Wu, Bin
    Attar, Eyal C.
    Stone, Richard M.
    BLOOD, 2020, 135 (07) : 463 - 471
  • [10] Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation
    Pasquier, Florence
    Chahine, Claude
    Marzac, Christophe
    de Botton, Stephane
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2020, 5 (06): : 429 - 438
12345